Company news
Petlife Pharmaceuticals Inc news in 2016
Petlife Pharmaceuticals Inc's news releases, calls and decks from 2016, newest first.
Correction: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product Line
December 7, 2016
PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product Line
December 7, 2016
PetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA Submission
December 6, 2016
PetLife Pharmaceuticals Updates Shareholders on the Company Progress with Vitalzul™ Studies and Additional Product Offerings
December 1, 2016
PetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion Venom's Ability to Eradicate Cancer Cells as Continued Support for PetLife's pre- INAD Studies of Vitalzul™
November 15, 2016
PetLife Pharmaceuticals and Lumleian, LLC Announce Partnership to Advance Development and Commercialization of Promising Veterinary Health Pipeline
October 27, 2016
PetLife Pharmaceuticals Announces the Addition of a Seasoned Marketing Specialist and Investor, Mrs. Vyvyan Campbell, to the Board of Directors
October 24, 2016
PetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific Officer with plans to expand its Current Portfolio of Veterinarian Drugs and Nutraceuticals
October 20, 2016
PetLife Pharmaceuticals is Pleased to Announce the Completion of the New Company Website
October 17, 2016
PetLife Pharmaceuticals Expands Cell Line Study with InnoVision in Preparation for FDA/CVM Registration Submission
October 13, 2016
PetLife Pharmaceuticals is Pleased to Showcase its New “Vitalzul™ Information Video” along with a Corporate Update
October 10, 2016
PetLife Pharmaceuticals Announces pre-INAD (Investigational New Animal Drug) Cell Lines Study of Vitalzul™ has Begun
September 7, 2016
PetLife Pharmaceuticals Sees Vitalzul™ as a Major Component in the Treatment of Cancer in Pets; Releases Vitalzul™ Information and Testimonial Video
September 1, 2016
PetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA Submission
August 25, 2016
PetLife Pharmaceuticals Announces Investor Analysts Research Report
August 23, 2016
PetLife Pharmaceuticals Rebrands all Products in Preparation for The FDA Registration Process
August 19, 2016
PetLife Pharmaceuticals, Inc. Issues Letter to Shareholders
August 16, 2016
PetLife Pharmaceuticals Holds First Medical Professional Investor Conference
August 1, 2016
PetLife Pharmaceuticals Adds Seasoned Medical Professionals to the Management Team
July 25, 2016
PetLife Pharmaceuticals Retains Invicto Group as their Investor Relations Firm
July 19, 2016
OTC Markets Group Welcomes Newly Verified OTCQB Companies – January 7
January 7, 2016